Karsten Häffner

2.7k total citations
33 papers, 1.1k citations indexed

About

Karsten Häffner is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Karsten Häffner has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 10 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in Karsten Häffner's work include Complement system in diseases (13 papers), Genetic and Kidney Cyst Diseases (8 papers) and Renal Diseases and Glomerulopathies (7 papers). Karsten Häffner is often cited by papers focused on Complement system in diseases (13 papers), Genetic and Kidney Cyst Diseases (8 papers) and Renal Diseases and Glomerulopathies (7 papers). Karsten Häffner collaborates with scholars based in Germany, United States and Switzerland. Karsten Häffner's co-authors include Heymut Omran, Heike Olbrich, Friedhelm Hildebrandt, Richard Reinhardt, Maimoona A. Zariwala, N. Konietzko, Andreas Kispert, Michael R. Knowles, Hannah M. Mitchison and Steffen Hennig and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Genetics.

In The Last Decade

Karsten Häffner

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karsten Häffner Germany 15 571 508 413 180 122 33 1.1k
Marie Legendre France 23 583 1.0× 741 1.5× 503 1.2× 202 1.1× 97 0.8× 82 1.6k
Mitali Patel United Kingdom 11 253 0.4× 179 0.4× 256 0.6× 339 1.9× 68 0.6× 19 839
Reetta Vuolteenaho Finland 16 104 0.2× 651 1.3× 356 0.9× 207 1.1× 159 1.3× 24 1.2k
Odile Cohen‐Haguenauer France 16 527 0.9× 647 1.3× 151 0.4× 173 1.0× 39 0.3× 52 1.2k
Hua Chang United States 15 255 0.4× 1.4k 2.8× 113 0.3× 119 0.7× 47 0.4× 34 1.8k
Yuki Hitomi Japan 16 279 0.5× 444 0.9× 53 0.1× 267 1.5× 32 0.3× 39 1.1k
H. D. Hager Germany 7 442 0.8× 745 1.5× 50 0.1× 79 0.4× 162 1.3× 10 1.1k
M. Mannens Netherlands 15 314 0.5× 595 1.2× 61 0.1× 78 0.4× 197 1.6× 30 836
Marat Gorivodsky Israel 17 322 0.6× 806 1.6× 93 0.2× 261 1.4× 79 0.6× 25 1.2k
Long Vien United States 9 139 0.2× 374 0.7× 40 0.1× 330 1.8× 29 0.2× 11 778

Countries citing papers authored by Karsten Häffner

Since Specialization
Citations

This map shows the geographic impact of Karsten Häffner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karsten Häffner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karsten Häffner more than expected).

Fields of papers citing papers by Karsten Häffner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karsten Häffner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karsten Häffner. The network helps show where Karsten Häffner may publish in the future.

Co-authorship network of co-authors of Karsten Häffner

This figure shows the co-authorship network connecting the top 25 collaborators of Karsten Häffner. A scholar is included among the top collaborators of Karsten Häffner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karsten Häffner. Karsten Häffner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rogg, Manuel, Eva L. Decker, Martin Pöhl, et al.. (2025). Thrombospondin-1 inhibits alternative complement pathway activation in antineutrophil cytoplasmic antibody-associated vasculitis. Journal of Clinical Investigation. 135(13). 2 indexed citations
2.
Dabrowska‐Schlepp, Paulina, Karsten Häffner, Anne Wolf, et al.. (2025). Moss-produced complement factor H (CPV-104) as a therapeutic regulator in complement-mediated diseases. Immunobiology. 230(4). 152989–152989.
3.
Dabrowska‐Schlepp, Paulina, Andreas Büsch, Andreas Schaaf, et al.. (2025). Effective long-term treatment with moss-produced factor H by overcoming the antibody response in a mouse model of C3G. Frontiers in Immunology. 16. 1535547–1535547. 1 indexed citations
4.
Liu, Xiaobo, Alexander T. Bauer, Alex Márki, et al.. (2025). Lipid nanotubes unmask neutrophils for complement attack. Blood. 147(12). 1338–1350.
5.
Büsch, Andreas, Andrea Hartmann, Marina Noris, et al.. (2024). Moss-produced human complement factor H with modified glycans has an extended half-life and improved biological activity. Frontiers in Immunology. 15. 1383123–1383123. 5 indexed citations
6.
Parsons, Juliana, Madeleine Müller, Sebastian N. W. Hoernstein, et al.. (2022). A synthetic protein as efficient multitarget regulator against complement over-activation. Communications Biology. 5(1). 152–152. 13 indexed citations
7.
Vidal‐y‐Sy, Sabine, Xiaobo Liu, Christian Meß, et al.. (2022). Impact of neutrophil extracellular traps on fluid properties, blood flow and complement activation. Frontiers in Immunology. 13. 1078891–1078891. 21 indexed citations
8.
Klämbt, Verena, Charlotte Gimpel, Martin Bald, et al.. (2020). Different approaches to long-term treatment of aHUS due to MCP mutations: a multicenter analysis. Pediatric Nephrology. 36(2). 463–471. 4 indexed citations
9.
Parsons, Juliana, Stefan Michelfelder, Sebastian N. W. Hoernstein, et al.. (2019). Recombinant Production of MFHR1, A Novel Synthetic Multitarget Complement Inhibitor, in Moss Bioreactors. Frontiers in Plant Science. 10. 260–260. 18 indexed citations
10.
Welte, Thomas, Maximilian Seidl, Karsten Häffner, et al.. (2018). Treating C3 glomerulopathy with eculizumab. BMC Nephrology. 19(1). 7–7. 41 indexed citations
11.
Riedl, Magdalena, Johannes Hofer, Thomas Giner, et al.. (2016). Novel biomarker and easy to perform ELISA for monitoring complement inhibition in patients with atypical hemolytic uremic syndrome treated with eculizumab. Journal of Immunological Methods. 435. 60–67. 8 indexed citations
12.
Raidt, Johanna, Julia Wallmeier, Rim Hjeij, et al.. (2014). Ciliary beat pattern and frequency in genetic variants of primary ciliary dyskinesia. European Respiratory Journal. 44(6). 1579–1588. 123 indexed citations
13.
Fehrenbach, Henry, Christian Decker, Tobias Eisenberger, et al.. (2014). Mutations in WDR19 encoding the intraflagellar transport component IFT144 cause a broad spectrum of ciliopathies. Pediatric Nephrology. 29(8). 1451–1456. 30 indexed citations
14.
Loges, Niki T., Heike Olbrich, Anita Becker-Heck, et al.. (2009). Deletions and Point Mutations of LRRC50 Cause Primary Ciliary Dyskinesia Due to Dynein Arm Defects. The American Journal of Human Genetics. 85(6). 883–889. 144 indexed citations
15.
Escobar, Héctor, Karsten Häffner, Michael Pohl, et al.. (2009). Acute Renal Failure Associated with Bilateral Enlargement of the Kidneys: A Rare Manifestation of Acute Lymphoblastic Leukemia (ALL). Klinische Pädiatrie. 221(3). 176–178. 4 indexed citations
16.
Häffner, Karsten, Lothar Bernd Zimmerhackl, Christian von Schnakenburg, M. Brandis, & Martin Pöhl. (2005). Complete remission of post-transplant FSGS recurrence by long-term plasmapheresis. Pediatric Nephrology. 20(7). 994–997. 12 indexed citations
17.
Omran, Heymut, et al.. (2001). Evidence for further genetic heterogeneity in nephronophthisis. Nephrology Dialysis Transplantation. 16(4). 755–758. 5 indexed citations
18.
Omran, Heymut, Carmen Fernández, Martin Jung, et al.. (2000). Identification of a New Gene Locus for Adolescent Nephronophthisis, on Chromosome 3q22 in a Large Venezuelan Pedigree. The American Journal of Human Genetics. 66(1). 118–127. 69 indexed citations
19.
Omran, Heymut, Karsten Häffner, Joachim Kuehr, et al.. (2000). Homozygosity Mapping of a Gene Locus for Primary Ciliary Dyskinesia on Chromosome 5p and Identification of the Heavy Dynein Chain DNAH5 as a Candidate Gene. American Journal of Respiratory Cell and Molecular Biology. 23(5). 696–702. 83 indexed citations
20.
Omran, Heymut, et al.. (1999). Exclusion of the candidate genes ACE and Bcl-2 for six families with nephronophthisis not linked to the NPH1 locus. Nephrology Dialysis Transplantation. 14(10). 2328–2331. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie Legendre Breakdown of academic impact, for papers by Mitali Patel Breakdown of academic impact, for papers by Reetta Vuolteenaho Breakdown of academic impact, for papers by Odile Cohen‐Haguenauer Breakdown of academic impact, for papers by Hua Chang Breakdown of academic impact, for papers by Yuki Hitomi Breakdown of academic impact, for papers by H. D. Hager Breakdown of academic impact, for papers by M. Mannens Breakdown of academic impact, for papers by Marat Gorivodsky Breakdown of academic impact, for papers by Long Vien
Rankless by CCL
2026